FASEB J.

Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously.

Saupe F, Reichel M, Huijbers EJ, ..., Hellman LT, Olsson AK

FASEB J. 31 (3) 1204-1214 [2017-03-00; online 2016-12-19]

Affiliated researcher SciLifeLab Fellow Sebastian Deindl

Vaccines targeting self-antigens: mechanisms and efficacy-determining parameters.

Saupe F, Huijbers EJ, Hein T, ..., Olsson AK, Hellman L

FASEB J. 29 (8) 3253-3262 [2015-08-00; online 2015-04-13]

Affiliated researcher

Endothelial cell spheroids as a versatile tool to study angiogenesis in vitro.

Heiss M, Hellström M, Kalén M, ..., Augustin HG, Korff T

FASEB J. 29 (7) 3076-3084 [2015-07-00; online 2015-04-09]

Affiliated researcher

VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation.

Huang H, Langenkamp E, Georganaki M, ..., Kreuger J, Dimberg A

FASEB J. 29 (1) 227-238 [2015-01-00; online 2014-10-31]

Affiliated researcher

The lung-specific proteome defined by integration of transcriptomics and antibody-based profiling.

Lindskog C, Fagerberg L, Hallström B, ..., Pontén F, Micke P

FASEB J. 28 (12) 5184-5196 [2014-12-00; online 2014-08-28]

Affiliated researcher

The human skeletal muscle transcriptome: sex differences, alternative splicing, and tissue homogeneity assessed with RNA sequencing.

Lindholm ME, Huss M, Solnestam BW, ..., Lundeberg J, Sundberg CJ

FASEB J. 28 (10) 4571-4581 [2014-10-00; online 2014-07-11]

Affiliated researcher

The genome of the heartworm, Dirofilaria immitis, reveals drug and vaccine targets.

Godel C, Kumar S, Koutsovoulos G, ..., Blaxter M, Mäser P

FASEB J. 26 (11) 4650-4661 [2012-11-00; online 2012-08-13]

Affiliated researcher